Genetic Polymorphisms of Matrix Metalloproteinases: Functional Importance in the Development of Chronic Obstructive Pulmonary Disease?

Author： Wallace A.M.   Sandford A.J.  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.2, Iss.3, 2002-01, pp. : 167-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs in Clinical Development for Chronic Obstructive Pulmonary Disease: Summary and Table

By  

Pharmaceutical Medicine, Vol. 25, Iss. 4, 2011-08 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite

Chronic obstructive pulmonary disease: new opportunities for drug development

By Barnes P.J.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 10, 1998-10 ,pp. : 415-423

Elsevier

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite

Roflumilast: In Chronic Obstructive Pulmonary Disease

By Sanford Mark  

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1615-1627

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of chronic obstructive pulmonary disease

By Hizawa Nobuyuki  

Pharmacogenomics, Vol. 14, Iss. 10, 2013-07 ,pp. : 1215-1225

Future Medicine

Access to resources Recommend Favorite